IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Springhill Fund Asset Management (HK) Co Ltd

Q4 2024 Holdings

Filed 2025-02-13 | 17 holdings | $61.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Verona Pharma PLC(VRNA)SPONSORED ADS925050106$6.3M135,45210.2%
Legend Biotech Corp(LEGN)SPONSORED ADS52490G102$6.2M190,80010.1%
Cytokinetics Inc(CYTK)COM NEW23282W605$6.1M130,73510.0%
Astrazeneca PLC(AZN)SPONSORED ADR046353108$5.0M76,5008.1%
Insmed Inc(INSM)COM PAR $.01457669307$4.8M69,5007.8%
Vera Therapeutics Inc(VERA)CL A92337R101$4.6M109,4007.5%
Cogent Biosciences Inc(COGT)COM19240Q201$4.3M548,5546.9%
Akero Therapeutics Inc(AKRO)COM00973Y108$4.2M151,2006.8%
Merus N VCOMN5749R100$3.5M83,8005.7%
Cullinan Therapeutics Inc(CGEM)COM230031106$3.4M276,4005.5%
Dyne Therapeutics Inc(DYN)COM26818M108$3.1M131,2005.0%
Nurix Therapeutics Inc(NRIX)COM67080M103$3.0M160,5004.9%
Bright Minds Biosciences Inc(DRUG)COM NEW10919W405$2.2M60,6483.5%
Bicycle Therapeutics PLC(BCYC)SPONSORED ADS088786108$1.6M116,4002.6%
Janux Therapeutics Inc(JANX)COM47103J105$1.6M29,6002.6%
Abivax SA(ABVX)SPONSORED ADS00370M103$1.5M207,6002.5%
Soleno Therapeutics Inc(SLNO)COM834203309$80.6K1,7930.1%